Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Auteur de référence en rhumatologie
49 articles scientifiques publiés — un praticien à la pointe de la recherche
Encadrant universitaire
Forme la prochaine génération de rhumatologues (1 thèse dirigée)
✨ Génération du profil synthétique IA en cours…
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Doctorant·e : Danièle Dubois-Laforgue
Source theses.fr — signal de direction d'équipe / statut PU-PH (à confirmer via le site universitaire).
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
42
42 articles ont été cités au moins 42fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
6 372
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
207
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
103
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Affiliations FR : Université Paris Cité · Assistance Publique – Hôpitaux de Paris · Maternité Port Royal
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Pregnancy in Women With Monogenic Diabetes due to Pathogenic Variants of the Glucokinase Gene: Lessons and Challenges
2022ArticleFrontiers in Endocrinology
Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial
2019ArticleThe Lancet. Diabetes & Endocrinology
mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases
2019ArticleKidney International
Next-generation sequencing identifies monogenic diabetes in 16% of patients with late adolescence/adult-onset diabetes selected on a clinical basis: a cross-sectional analysis
2019ArticleBMC Medicine
Diabetes, Associated Clinical Spectrum, Long-term Prognosis, and Genotype/Phenotype Correlations in 201 Adult Patients With Hepatocyte Nuclear Factor 1B ( HNF1B ) Molecular Defects
2017ArticleDiabetes Care
Clinical Characteristics and Diagnostic Criteria of Maturity-Onset Diabetes Of The Young (MODY) due to Molecular Anomalies of the HNF1A Gene
2011ArticleJournal of Clinical Endocrinology and Metabolism
The Clinical Variability of Maternally Inherited Diabetes and Deafness Is Associated with the Degree of Heteroplasmy in Blood Leukocytes
2009ArticleJournal of Clinical Endocrinology and Metabolism
The Type and the Position of HNF1A Mutation Modulate Age at Diagnosis of Diabetes in Patients with Maturity-Onset Diabetes of the Young (MODY)-3
2008ArticleDiabetes
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Annals of internal medicine · 2004
Diabetes · 2005
Maturity-onset diabetes of the young (MODY) 5 is caused by mutations in the TCF2 gene encoding the transcription factor hepatocyte nuclear factor-1β. However, in 60% of the patients with a phenotype suggesting MODY5, no point mutation is detected in TCF2. We have hypothesized that large genomic rearrangements of TCF2 that are missed by conventional screening methods may account for this observation. In 40 unrelated patients presenting with MODY5 phenotype, TCF2 was screened for mutations by sequencing. Patients without mutations were then screened for TCF2 rearrangements by the quantitative multiplex PCR of short fluorescent fragments (QMPSF). Among the 40 patients, the overall detection rate was 70%: 18 had point mutations, 9 had whole-gene deletions, and 1 had a deletion of a single exon. Similar phenotypes were observed in patients with mutations and in subjects with large deletions. These results suggest that MODY5 is more prevalent than previously reported, with one-third of the cases resulting from large deletions of TCF2. Because QMPSF is more rapid and cost effective than sequencing, we propose that patients whose phenotype is consistent with MODY5 should be screened first with the QMPSF assay. In addition, other MODY genes should be screened for large genomic rearrangements.
Journal of the American Society of Nephrology : JASN · 1999
Abstract. It has been shown previously that proteinase 3 (PR3), a neutrophil intracellular protease that is the main antigen of antineutrophil cytoplasm (ANCA) autoantibodies, is present on the plasma membrane of a subset of freshly isolated neutrophils. This study shows that the size of this subset of membrane PR3-positive (mPR3+) neutrophils is a stable feature of a given individual, most likely genetically controlled. It ranges from 0 to 100% of neutrophils and allows us to define a new polymorphism in the healthy population, with three discrete phenotypes corresponding respectively to less than 20% mPR3+ neutrophils (mPR3low) or to a mean percentage of 47% (mPR3intermediate) and 71.5% (mPR3high) mPR3+ neutrophils. The frequency of the mPR3high phenotype was significantly increased in patients with ANCA-associated vasculitis (85% versus 55% in healthy subjects). The percentage of mPR3+ neutrophils was not affected by disease activity, relapses, or therapy, and did not reflect in vivo cell activation. In addition, mPR3+ phenotypes were normally distributed in cystic fibrosis patients, indicating that infection and/or inflammation per se do not lead to a high percentage of mPR3+ neutrophils. The frequency of the mPR3high phenotype was not related to anti-PR3 autoimmunization, since it was increased in vasculitic patients regardless of the ANCA specificity (anti-PR3, anti-myeloperoxidase, or unknown). Interestingly, the frequency of the mPR3high phenotype was also increased in patients with rheumatoid arthritis. It was normal in type I-diabetes, a T cell-dependent autoimmune disease. It is proposed here that a high proportion of membrane PR3-positive neutrophils could favor the occurrence or the progression of chronic inflammatory diseases.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Diabetologia · 2025 · Journal Article
Ciangura C, Seco A, Saint-Martin C, Ancel PY, et al.
Critical care (London, England) · 2023 · Multicenter Study
Giacobbe DR, Dettori S, Di Pilato V, Asperges E, et al.
Acta diabetologica · 2021 · Journal Article
Lebbar M, Timsit J, Luyton C, Marchand L
Frontiers in endocrinology · 2021 · Journal Article
Timsit J, Ciangura C, Dubois-Laforgue D, Saint-Martin C, et al.
Heliyon · 2020 · Journal Article
Pénager C, Bardet P, Timsit J, Lepercq J
Journal of diabetes · 2020 · Journal Article
Haddouche A, Bellanne-Chantelot C, Rod A, Fournier L, et al.
Kidney international · 2019 · Journal Article
Johnson SC, Martinez F, Bitto A, Gonzalez B, et al.
BMC medicine · 2019 · Journal Article
Donath X, Saint-Martin C, Dubois-Laforgue D, Rajasingham R, et al.
Diabetes care · 2018 · Letter
Dubois-Laforgue D, Cornu E, Saint-Martin C, Coste J, et al.
Current infectious disease reports · 2017 · Journal Article
Cantier M, Mazighi M, Klein I, Desilles JP, et al.
Diabetes care · 2017 · Journal Article
Dubois-Laforgue D, Cornu E, Saint-Martin C, Coste J, et al.
Canadian journal of diabetes · 2016 · Journal Article
Timsit J, Saint-Martin C, Dubois-Laforgue D, Bellanné-Chantelot C
Kidney international · 2016 · Journal Article
Terryn S, Tanaka K, Lengelé JP, Olinger E, et al.
European journal of human genetics : EJHG · 2014 · Journal Article
Colclough K, Saint-Martin C, Timsit J, Ellard S, et al.
Diabetes care · 2014 · Journal Article
Dubois-Laforgue D, Bellanné-Chantelot C, Subra JF, Timsit J
Obstetrics and gynecology · 2013 · Journal Article
Miailhe G, Le Ray C, Timsit J, Lepercq J
The Journal of clinical endocrinology and metabolism · 2011 · Journal Article
Bellanné-Chantelot C, Lévy DJ, Carette C, Saint-Martin C, et al.
Obstetrics and gynecology · 2010 · Journal Article
Lepercq J, Le Meaux JP, Agman A, Timsit J
Nature reviews. Nephrology · 2009 · Case Reports
Zuber J, Bellanné-Chantelot C, Carette C, Canaud G, et al.
Diabetes · 2008 · Journal Article
Cheurfa N, Dubois-Laforgue D, Ferrarezi DA, Reis AF, et al.
Diabetes · 2008 · Journal Article
Bellanné-Chantelot C, Carette C, Riveline JP, Valéro R, et al.
The Journal of clinical endocrinology and metabolism · 2007 · Case Reports
Carette C, Vaury C, Barthélémy A, Clauin S, et al.
Arquivos brasileiros de endocrinologia e metabologia · 2007 · Journal Article
Barthelemy O, Le Feuvre C, Timsit J
Diabetes · 2007 · Journal Article
Chelala C, Duchatelet S, Joffret ML, Bergholdt R, et al.
Diabetes · 2005 · Journal Article
Bellanné-Chantelot C, Clauin S, Chauveau D, Collin P, et al.
Molecular genetics and metabolism · 2005 · Journal Article
Ghandil P, Chelala C, Dubois-Laforgue D, Senée V, et al.
Human molecular genetics · 2005 · Journal Article
Rebouissou S, Vasiliu V, Thomas C, Bellanné-Chantelot C, et al.
Treatments in endocrinology · 2005 · Journal Article
Timsit J, Bellanné-Chantelot C, Dubois-Laforgue D, Velho G
Annals of internal medicine · 2004 · Journal Article
Bellanné-Chantelot C, Chauveau D, Gautier JF, Dubois-Laforgue D, et al.
Medecine sciences : M/S · 2003 · English Abstract
Velho G, Bellanné-Chantelot C, Timsit J
Diabetes/metabolism research and reviews · 2002 · Clinical Trial
Assan R, Blanchet F, Feutren G, Timsit J, et al.
Journal of the American Society of Nephrology : JASN · 1999 · Comparative Study
Witko-Sarsat V, Lesavre P, Lopez S, Bessou G, et al.
Revue du rhumatisme et des maladies osteo-articulaires · 1979 · Comparative Study
Auquier L, Paolaggi JB, Limon J, Timsit JL, et al.
Agents and actions · 1973 · Journal Article
Giroud JP, Spector WG, Timsit J, Willoughby DA
Autoimmunity reviews · 2025 · Letter
Kachaner A, Mageau A, Timsit JF, Rio J, et al.
PloS one · 2024 · Journal Article
Mageau A, Géradin C, Sallah K, Papo T, et al.
Scientific reports · 2022 · Journal Article
Beydon M, Nicaise-Roland P, Mageau A, Farkh C, et al.
Journal of internal medicine · 2024 · Journal Article
Mageau A, Helary A, Ruckly S, Strukov A, et al.
Best practice & research. Clinical endocrinology & metabolism · 2010 · Journal Article
Wucher H, Lepercq J, Timsit J
Diabetes care · 2004 · Journal Article
Lepercq J, Coste J, Theau A, Dubois-Laforgue D, et al.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2008 · Journal Article
Duchatelet S, Caillat-Zucman S, Dubois-Laforgue D, Blanc H, et al.
Molecular genetics and metabolism · 2004 · Journal Article
Reis AF, Dubois-Laforgue D, Bellanné-Chantelot C, Timsit J, et al.
Clinical endocrinology · 2003 · Journal Article
Roussel R, Reis AF, Dubois-Laforgue D, Bellanné-Chantelot C, et al.
Clinical endocrinology · 2003 · Journal Article
Roussel R, Reis AF, Dubois-Laforgue D, Bellanné-Chantelot C, et al.
La Revue du praticien · 2003 · Journal Article
Timsit J, Dubois-Laforgue D
Next-generation sequencing identifies monogenic diabetes in 16% of patients with late adolescence/adult-onset diabetes selected on a clinical basis: a cross-sectional analysis
Abstract Background Monogenic diabetes (MgD) accounts for 1–2% of all diabetes cases. In adults, MgD is difficult to distinguish from common diabetes causes. We assessed the diagnosis rate and genetic spectrum of MgD usi
Next-generation sequencing identifies monogenic diabetes in 16% of patients with late adolescence/adult-onset diabetes selected on a clinical basis: a cross-sectional analysis
Abstract Background Monogenic diabetes (MgD) accounts for 1–2% of all diabetes cases. In adults, MgD is difficult to distinguish from common diabetes causes. We assessed the diagnosis rate and genetic spectrum of MgD usi
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).
Respirology (Carlton, Vic.) · 2022 · Journal Article
Mageau A, Borie R, Crestani B, Timsit JF, et al.
Annals of the rheumatic diseases · 2022 · Journal Article
Mageau A, Papo T, Ruckly S, Strukov A, et al.
Annals of the rheumatic diseases · 2021 · Research Support, Non-U.S. Gov't
Mageau A, Aldebert G, Van Gysel D, Papo T, et al.
The Journal of infection · 2019 · Comparative Study
Mageau A, Sacré K, Perozziello A, Ruckly S, et al.
Autoimmunity reviews · 2019 · Journal Article
Mageau A, Timsit JF, Perrozziello A, Ruckly S, et al.